vTv Therapeutics (VTVT) Stock Chart & Stock Price History $14.95 -0.05 (-0.33%) As of 09:44 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock vTv Therapeutics Stock Price Performance The vTv Therapeutics (VTVT) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 18.22%, with a year-to-date return of 8.25%. In the past month, the stock has decreased 11.59%, reflecting recent market activity. As of the latest close, vTv Therapeutics traded at $14.67 with a market cap of $46.80 million and volume of 1,671 shares. Five years ago, the stock traded at a split-adjusted price of $90.80, representing a 83.54% decrease over that period. At the time, it had a market cap of $152.49 million and a volume of 5,163 shares. Receive VTVT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for vTv Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+3.17%1 Month Performance-11.59%3 Month Performance-14.57%Year-To-Date Performance+8.25%1 Year Performance-18.22%5 Year Performance-83.54% VTVT Stock Chart for Wednesday, July, 2, 2025 VTVT Chart by TradingView vTv Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/01/2025$15.00$14.67-2.20%$14.95$14.531,671 shs$46.80 million06/30/2025$14.49$15.00+3.52%$15.56$14.991,639 shs$47.85 million06/27/2025$15.55$14.49-6.82%$16.10$14.4952,234 shs$46.22 million06/26/2025$16.28$15.55-4.48%$16.76$14.8043,815 shs$49.60 million06/25/2025$15.80$16.28+3.04%$16.28$15.413,315 shs$51.93 million06/24/2025$15.61$15.80+1.25%$15.94$15.3421,870 shs$50.40 million06/23/2025$15.56$15.61+0.32%$15.18$15.18503 shs$49.78 million06/20/2025$15.69$15.56-0.86%$16.20$15.551,412 shs$49.62 million06/19/2025$15.69$15.69$16.03$15.171,390 shs$50.05 million06/18/2025$15.67$15.69+0.16%$16.03$15.171,390 shs$50.05 million Get the Latest News and Ratings for VTVT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for vTv Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 06/17/2025$15.89$15.67-1.42%$15.72$15.72720 shs$50.05 million06/16/2025$15.46$15.89+2.78%$15.89$15.83853 shs$50.77 million06/13/2025$16.00$15.46-3.37%$16.10$15.3512,440 shs$49.40 million06/12/2025$16.50$16.00-3.03%$16.31$16.001,525 shs$51.12 million06/11/2025$16.92$16.50-2.45%$16.54$16.54417 shs$52.72 million06/10/2025$16.10$16.92+5.06%$16.59$16.052,359 shs$54.04 million06/09/2025$16.67$16.10-3.42%$16.61$16.61716 shs$51.44 million06/06/2025$16.53$16.67+0.88%$16.31$16.312,841 shs$53.26 million06/05/2025$16.00$16.53+3.28%$16.67$16.67735 shs$52.80 million06/04/2025$16.30$16.00-1.84%$16.70$16.003,257 shs$51.12 million06/03/2025$16.91$16.30-3.61%$16.47$15.922,472 shs$52.08 million06/02/2025$15.79$16.91+7.09%$16.54$16.022,200 shs$54.03 million Related Companies CTMX Stock Price Chart OGI Stock Price Chart GNFT Stock Price Chart FDMT Stock Price Chart IPHA Stock Price Chart VTYX Stock Price Chart DERM Stock Price Chart PBYI Stock Price Chart DMAC Stock Price Chart SPRO Stock Price Chart Receive VTVT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for vTv Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:VTVT) was last updated on 7/2/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredIsrael-Iran WAR Could Destroy Trump's PresidencyThe missiles are already flying. Israel and Iran are now in direct military conflict — and this couldn't ha...American Alternative | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredThe #1 AI Energy StockNearly $600 billion is projected to be spent on AI data centers this year. That's because the ones being bu...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding vTv Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share vTv Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.